The clinically approved proteasome inhibitor PS-341 efficiently blocks influenza A virus and vesicular stomatitis virus propagation by establishing an antiviral state.

The clinically approved proteasome inhibitor PS-341 efficiently blocks influenza A virus and vesicular stomatitis virus propagation by establishing an antiviral state.

Item
http://www.wikidata.org/entity/Q39686446
Multi-Omics Studies towards Novel Modulators of Influenza A Virus-Host InteractionInterplay between influenza A virus and host factors: targets for antiviral intervention.Obatoclax, saliphenylhalamide, and gemcitabine inhibit influenza a virus infection.Bortezomib-induced unfolded protein response increases oncolytic HSV-1 replication resulting in synergistic antitumor effects.The Modified JiuWei QiangHuo Decoction Alleviated Severe Lung Injury Induced by H1N1 Influenza Virus by Regulating the NF- κ B Pathway in MiceRegulation of the nucleocytoplasmic trafficking of viral and cellular proteins by ubiquitin and small ubiquitin-related modifiers.Oncolytic vesicular stomatitis virus and bortezomib are antagonistic against myeloma cells in vitro but have additive anti-myeloma activity in vivo.Poxvirus exploitation of the ubiquitin-proteasome system.Potential applications for antiviral therapy and prophylaxis in bovine medicine.Broad-spectrum antiviral agents.Phosphorylation of influenza A virus NS1 protein at threonine 49 suppresses its interferon antagonistic activity.Proteasomes raise the microtubule dynamics in influenza A (H1N1) virus-infected LLC-MK2 cells.The adaptor protein FHL2 enhances the cellular innate immune response to influenza A virus infection.The emerging influenza virus threat: status and new prospects for its therapy and control.
P2860

The clinically approved proteasome inhibitor PS-341 efficiently blocks influenza A virus and vesicular stomatitis virus propagation by establishing an antiviral state.

Item
http://www.wikidata.org/entity/Q39686446
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
The clinically approved protea ...... tablishing an antiviral state.
@en
The clinically approved protea ...... tablishing an antiviral state.
@nl
type
label
The clinically approved protea ...... tablishing an antiviral state.
@en
The clinically approved protea ...... tablishing an antiviral state.
@nl
prefLabel
The clinically approved protea ...... tablishing an antiviral state.
@en
The clinically approved protea ...... tablishing an antiviral state.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P932
P356
P1433
P1476
The clinically approved protea ...... tablishing an antiviral state.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P932